Showing results (131-140 of 920) with videos related to
Sort By:
Pageof 92
The Journal of Infectious Diseases|February 1, 1980
Model of neonatal meningitis caused by Escherichia coli K1 in guinea pigsR E Sinai, M I Marks, K R Powell, et al.Journal of Clinical Microbiology|June 1, 1979
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stoolsC H Pai, S Sorger, L Lafleur, et al.Antimicrobial Agents and Chemotherapy|October 1, 1990
Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosisJ C Akaniro, C E Vidaurre, H R Stutman, et al.Antimicrobial Agents and Chemotherapy|November 1, 1990
In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputumA G Arguedas, J C Akaniro, H R Stutman, et al.Antimicrobial Agents and Chemotherapy|July 1, 1990
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputumH R Stutman, J C Akaniro, C E Vidaurre, et al.The Journal of Pediatrics|July 1, 1980
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?P H Beaudry, M I Marks, D McDougall, et al.Clinical Nuclear Medicine|December 1, 1978
Serial 67Ga-citrate imaging during treatment of acute osteomyelitis in childhoodE Kolyvas, L Rosenthall, G A Ahronheim, et al.The Pediatric Infectious Disease Journal|February 1, 1987
Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemicD A Conrad, J C Christenson, J L Waner, et al.Journal of Medical Microbiology|February 1, 1986
Comparative analysis of Haemophilus influenzae type b and Escherichia coli J5 lipopolysaccharidesM R Hill, K L McKinney, M I Marks, et al.Chemotherapy|January 1, 1985
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosisC Laferriere, H R Stutman, M I Marks, et al.Pageof 92